Methicillin-resistant Staphylococcus aureus preventing strategy in cardiac surgery

Aikaterini Mastoraki1, Ioannis Kriaras, Evangelia Douka

  • 1Department of Surgical Intensive Care Unit, Onassis Cardiac Surgery Center, 356 Sygrou Ave, 17674 Athens, Greece. drkamast@yahoo.gr

Abstract

Insights

Implementing a comprehensive methicillin-resistant Staphylococcus aureus (MRSA) prevention strategy, including screening and prompt treatment, significantly reduced MRSA spread in cardiovascular surgical patients. This approach lowered infection rates and associated mortality.

Area of Science:

  • Infectious Diseases
  • Hospital Epidemiology
  • Surgical Site Infections

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat in healthcare settings, particularly in vulnerable patient populations like those undergoing cardiovascular surgery.
  • Effective prevention strategies are crucial to mitigate the morbidity and mortality associated with MRSA infections.

Purpose of the Study:

  • To evaluate the effectiveness of an institutional MRSA prevention strategy.
  • To determine the incidence, morbidity, and mortality associated with MRSA in cardiovascular surgical patients.

Main Methods:

  • A prospective observational cohort study of 15,270 cardiovascular surgical patients from 1997 to 2005.
  • Implementation of active screening for MRSA carriers via nasal swabs in high-risk patients and newly employed healthcare workers.
  • Isolation and prompt treatment of MRSA carriers and infected patients.

Main Results:

  • The overall infection rate was 5.4%, with an MRSA-associated infection rate of 0.2% (86 MRSA cases out of 15,270 patients).
  • MRSA-infected patients experienced a significantly longer ICU stay (46.5 days vs. 1.7 days) and a higher mortality rate (30% vs. 2.9%) compared to non-MRSA infected patients.
  • MRSA was identified in various sites, including tracheal secretions, surgical wounds, drainage fluid, and blood cultures, leading to complications like post-sternotomy mediastinitis and severe sepsis.

Conclusions:

  • A multi-faceted MRSA prevention strategy, encompassing early detection, isolation, and treatment of infected patients and carriers, effectively curbed pathogen spread.
  • The findings underscore the importance of rigorous screening and management protocols for MRSA in high-risk surgical populations.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...